SHIELD THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.35 GBX | +10.20% |
|
-8.47% | -79.85% |
| 22/02 | Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024 | |
| 21/02 | FTSE 100 takes hit ahead of FOMC minutes | AN |
Chart calendar Shield Therapeutics plc
95b002f2aa.Sf053fo2y0Sew0FoHSl_z3QC2ng-rPT8TmQnc9SKju4.II4NicpYozbYrQ04L2UNnDY370pZ_421OhZPMIHV3p4KsG-wsl38G9z0dQ~c1ad4361341a669bec42d5dbfd10d2b4
Upcoming events on Shield Therapeutics plc
Past events on Shield Therapeutics plc
| 22/02/2024 07:30 pm | Q4 2023 Sales and Revenue Call - Trading Update |
| 21/02/2024 12:30 pm | Q4 2023 Sales and Revenue Release - Trading Update |
| 30/10/2023 09:15 pm | Women’s Healthcare Conference |
| 28/09/2023 09:00 pm | Q2 2023 Earnings Call |
| 28/09/2023 11:30 am | Q2 2023 Earnings Release |
| 12/09/2023 | H.C. Wainwright Global Investment Conference |
| 28/06/2023 06:30 pm | Annual General Meeting |
| 27/04/2023 09:00 pm | Q4 2022 Earnings Call |
| 27/04/2023 11:30 am | Q4 2022 Earnings Release |
| 09/02/2023 12:30 pm | Q4 2022 Sales and Revenue Release - Trading Update |
| 05/01/2023 07:30 pm | Shareholders Meeting |
| 14/12/2022 10:00 pm | Investor Meeting |
| 25/10/2022 07:30 pm | American College of Gastroenterology Scientific Meeting - Poster No - D0361 |
| 08/09/2022 09:00 pm | Interim 2022 Earnings Call - Investor |
| 08/09/2022 06:30 pm | Interim 2022 Earnings Call - Analyst |
| 08/09/2022 11:30 am | Interim 2022 Earnings Release |
| 27/07/2022 07:30 pm | Shareholders Meeting |
| 27/07/2022 06:30 pm | Annual General Meeting |
| 30/06/2022 09:00 pm | FY 2021 Earnings Call - Investor |
| 30/06/2022 06:00 pm | FY 2021 Earnings Call - Analyst |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 11,9 11,9 -0.45% | 0,72 1,23 -41.71% | 10,4 9,40 10.46% | 1,52 2,01 -24.51% | 4,47 7,50 -40.48% | 12,4 |
|
EBITDA Million GBP | Released Forecast Spread | -2,81 -3,60 21.83% | -6,41 -6,72 4.57% | 0,55 0,34 61.39% | -17,7 -18,7 5.03% | -23,3 -17,7 -31.55% | -22,9 |
|
EBIT Million GBP | Released Forecast Spread | -5,17 -4,96 -4.1% | -9,04 -8,53 -5.98% | -2,15 -1,62 -32.62% | -20,0 -20,9 4.45% | -25,7 -19,4 -32.6% | -23,3 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -5,15 -5,87 12.23% | -9,07 -10,2 11.51% | -1,89 -2,24 15.77% | -19,6 -21,2 7.9% | -40,1 -19,6 -104.44% | -25,5 |
|
Net income Million GBP | Released Forecast Spread | -1,79 -2,59 30.61% | -8,80 -7,23 -21.71% | -2,63 -1,53 -71.5% | -19,3 -21,4 9.72% | -40,4 -19,9 -103.42% | -27,0 |
|
EPS GBP | Released Forecast Spread | -0,02 -0,02 13.42% | -0,08 -0,06 -29.03% | -0,02 -0,01 -75.9% | -0,09 -0,11 16.29% | -0,17 -0,09 -95.97% | -0,04 |
| Announcement Date | 03/04/19 | 21/05/20 | 29/04/21 | 30/06/22 | 27/04/23 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2022 S1 | 2023 S1 |
|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 8,92 0,30 2873% | 2,03 1,75 16.06% | 4,33 2,70 60.52% |
|
EBIT Million GBP | Released Forecast Spread | -11,7 -12,2 3.9% | -11,5 -15,0 23.06% | |
| Announcement Date | 16/09/20 | 08/09/22 | 28/09/23 |
More events
Past sector events for Shield Therapeutics plc
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- STX Stock
- Calendar Shield Therapeutics plc
